Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Link to SEPIO compliant JSON-LD document

Variant: NM_000162.5(GCK):c.1020-1G>A

CA367399428

447378 (ClinVar)

Gene: GCK

Condition: monogenic diabetes

Inheritance Mode: Semidominant inheritance

Link to MONDO

UUID: 765c2ee2-101a-45d7-894e-7f0aeaa1633c

HGVS expressions

NM_000162.5:c.1020-1G>A

NM_000162.5(GCK):c.1020-1G>A

NC_000007.14:g.44145731C>T

CM000669.2:g.44145731C>T

NC_000007.13:g.44185330C>T

CM000669.1:g.44185330C>T

NC_000007.12:g.44151855C>T

NG_008847.1:g.48693G>A

NG_008847.2:g.57440G>A

ENST00000395796.8:c.*1018-1G>A

ENST00000616242.5:c.*140-1G>A

ENST00000683378.1:n.246-1G>A

ENST00000336642.9:c.54-1G>A

ENST00000345378.7:c.1023-1G>A

ENST00000403799.8:c.1020-1G>A

ENST00000671824.1:c.1083-1G>A

ENST00000672743.1:n.32-1G>A

ENST00000673284.1:c.1020-1G>A

ENST00000336642.8:c.72-1G>A

ENST00000345378.6:c.1023-1G>A

ENST00000395796.7:c.1017-1G>A

ENST00000403799.7:c.1020-1G>A

ENST00000437084.1:c.969-1G>A

ENST00000459642.1:n.399G>A

ENST00000473353.1:n.318-1G>A

ENST00000616242.4:c.1017-1G>A

NM_000162.3:c.1020-1G>A

NM_033507.1:c.1023-1G>A

NM_033508.1:c.1017-1G>A

NM_000162.4:c.1020-1G>A

NM_001354800.1:c.1020-1G>A

NM_001354801.1:c.9-1G>A

NM_001354802.1:c.-121-1G>A

NM_001354803.1:c.54-1G>A

NM_033507.2:c.1023-1G>A

NM_033508.2:c.1017-1G>A

NM_033507.3:c.1023-1G>A

NM_033508.3:c.1017-1G>A

NM_001354803.2:c.54-1G>A

Pathogenic

PP4_Moderate PVS1 PM2_Supporting

PS4 PP1

Evidence Links 0

Expert Panel

Monogenic Diabetes VCEP

Criteria Specification Information

Criteria Specification: ClinGen Monogenic Diabetes Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for GCK Version 1.3.0

Criteria Specification Approval History

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Monogenic Diabetes VCEP

The c.1020-1G>A variant in the glucokinase gene, GCK, is predicted to remove a canonical splice acceptor site in intron 8 of NM_000162.5. This variant is predicted to cause skipping of biologically-relevant exon 9 of 10, resulting in deletion of >10% of a protein encoded by a gene in which loss-of-function is an established disease mechanism (PVS1; PMID: 19790256). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant was identified in 3 apparently unrelated individuals with hyperglycemia; however, PS4_Moderate cannot be applied because this number is below the ClinGen MDEP threshold (internal lab contributors). Two of these individuals had a clinical history highly specific for GCK-hyperglycemia (FBG 5.5-8 mmol/L and HbA1c 5.6 - 7.6% and negative antibodies or 2 hour OGTT increment < 3 mmol/L)(PP4_Moderate, internal lab contributors). This variant segregated with hyperglycemia with 2 informative meioses in a single family; however, this does not meet the thresholds for PP1 set by the ClinGen MDEP (PMID: 27236918, internal lab contributors). In summary, c.1020-1G>A meets the criteria to be classified as pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.3, approved 8/11/2023): PVS1, PP4_Moderate, PM2_Supporting.

PP4_Moderate

This variant was identified in 2 individuals with a clinical history highly specific for GCK-hyperglycemia (FBG 5.5-8 mmol/L and HbA1c 5.6 - 7.6% and negative antibodies or 2 hour OGTT increment < 3 mmol/L)(PP4_Moderate, internal lab contributors).

PVS1

This variant is predicted to cause skipping of biologically-relevant exon 9 of 10, resulting in deletion of >10% of a protein encoded by a gene in which loss-of-function is an established disease mechanism (PVS1; PMID: 19790256).

PM2_Supporting

This variant is absent from gnomAD v2.1.1 (PM2_Supporting).

PS4

This variant was identified in 3 apparently unrelated individuals with hyperglycemia; however, PS4_Moderate cannot be applied because this number is below the ClinGen MDEP threshold (internal lab contributors).

PP1

This variant segregated with hyperglycemia with 2 informative meioses in a single family; however, this does not meet the thresholds for PP1 set by the ClinGen MDEP (PMID: 27236918, internal lab contributors).

Approved on: 2024-03-31

Published on: 2024-03-31

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.